Short Dental Implants (5 mm) Versus Long Dental Implants (10 mm) (NCT04144322) | Clinical Trial Compass
CompletedNot Applicable
Short Dental Implants (5 mm) Versus Long Dental Implants (10 mm)
United States34 participantsStarted 2019-10-14
Plain-language summary
The purpose of this study is to evaluate the survival rate of 5 mm short implants compared to longer implants (10 mm) placed in sinus-grafted sites.
Primary aim: Compare bone loss between the two groups Secondary aim: Compare surgical time and patient-reported outcomes (satisfaction and post-operative pain)
Who can participate
Age range
20 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 20-70 years at enrollment
* Systemically healthy patients
* Full-mouth plaque score and full-mouth bleeding score ≤ 30% (measured at four sites per tooth)
* In need of one premolar or 1st molar dental implant in the maxillary area
* Neighboring teeth to the planned implant must have natural root(s) or implant supported restoration.
* Presence of natural tooth/teeth, partial prosthesis and/or implants in the opposite jaw in contact with the planned crown/s deemed by the investigator as likely to present an initially stable implant situation
* Residual bone height under the maxillary sinus between 5 to 7 mm and a width of at least 7 mm, as measured on cone beam computer tomography (CBCT) scans.
Exclusion Criteria:
* Unlikely to be able to comply with study procedures
* Uncontrolled pathologic processes in the oral cavity
* History of head and neck chemotherapy within 5 years prior to surgery
* Systemic or local disease or condition that could compromise post-operative healing and/or osseointegration
* Uncontrolled diabetes mellitus HbA1c \>8
* Taking corticosteroids, IV bisphosphonates, or any other medication that could influence post-operative healing and/or osseointegration
* Smokes more than 10 cigarettes/day
* Bruxer
* Present alcohol and/or drug abuser
* Pregnant, unsure pregnancy status, or lactating females (self-reported)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.